Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Adverse Event Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Adverse Event Reporting
Login
menu
Home
Active Ingredients
SARS-CoV-2 spike protein (B.1.351 strain) produced by recombinant DNA technology
SARS-CoV-2 spike protein (B.1.351 strain) produced by recombinant DNA technology
Medicine
Status
PIL
SPC
XPIL
Legal Category
Active Ingredient(s)
Company
VidPrevtyn Beta solution and emulsion for emulsion for injection
Updated
PIL
26/09/23
SPC
26/09/23
No
C
SARS-CoV-2 spike protein (B.1.351 strain) produced by recombinant DNA technology
Sanofi Pasteur
Direct Healthcare Professional Communications
Documents associated with this medicine were updated in the last 30 days.
Date of Update on Medicines.ie
Product subject to restricted prescription (C)
